A21A (p.Ala21Ala) variant of EGFR (Epidermal growth factor receptor)
A21A (p.Ala21Ala) in EGFR (Epidermal growth factor receptor) is a synonymous change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.22 / 1. The record also includes population frequency data, experimental measurements, published literature, and structural context.
A21A (p.Ala21Ala) variant details
- p.Ala21Ala
- rs1421885942
- gnomAD 7-55019340-G-T
- Synonymous
- Variant Prioritization Score for Impact Estimate 0.219
- CADD 11.00
- Population evidence available
- Structural context available
- Dabrafenib and Cetuximab HT-29 cells, base editing z-scores (predicted consequen: score -0.636
- Literature evidence available